Search

Bharati R Dhruva

Examiner (ID: 3913)

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
2
Issued Applications
1
Pending Applications
1
Abandoned Applications
0

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6925372 [patent_doc_number] => 20050238627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer' [patent_app_type] => utility [patent_app_number] => 11/071862 [patent_app_country] => US [patent_app_date] => 2005-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 39938 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20050238627.pdf [firstpage_image] =>[orig_patent_app_number] => 11071862 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/071862
Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer Mar 1, 2005 Abandoned
Array ( [id] => 5894355 [patent_doc_number] => 20060002894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Method for introducing a biological molecule using a viral envelope and composition and system therefor' [patent_app_type] => utility [patent_app_number] => 11/067109 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18009 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002894.pdf [firstpage_image] =>[orig_patent_app_number] => 11067109 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/067109
Method for introducing a biological molecule using a viral envelope and heparin and system therefore Feb 24, 2005 Issued
Array ( [id] => 5726354 [patent_doc_number] => 20060057114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Methods of using vectors to treat metabolic disorders' [patent_app_type] => utility [patent_app_number] => 11/057410 [patent_app_country] => US [patent_app_date] => 2005-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26068 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057114.pdf [firstpage_image] =>[orig_patent_app_number] => 11057410 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/057410
Methods of treating lysosomal storage related diseases by gene therapy Feb 13, 2005 Issued
Array ( [id] => 6983856 [patent_doc_number] => 20050153926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Method for the immobilization of oligonucleotides' [patent_app_type] => utility [patent_app_number] => 11/054650 [patent_app_country] => US [patent_app_date] => 2005-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15321 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 52 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153926.pdf [firstpage_image] =>[orig_patent_app_number] => 11054650 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/054650
Method for the immobilization of oligonucleotides Feb 8, 2005 Abandoned
Array ( [id] => 5343487 [patent_doc_number] => 20090182137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Vesicle for separating substances from liquid media' [patent_app_type] => utility [patent_app_number] => 10/588205 [patent_app_country] => US [patent_app_date] => 2005-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6560 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20090182137.pdf [firstpage_image] =>[orig_patent_app_number] => 10588205 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/588205
Vesicle for separating substances from liquid media Feb 1, 2005 Abandoned
Array ( [id] => 8188400 [patent_doc_number] => 08182834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Ternary non-lamellar lipid compositions' [patent_app_type] => utility [patent_app_number] => 10/586777 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 8860 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/182/08182834.pdf [firstpage_image] =>[orig_patent_app_number] => 10586777 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586777
Ternary non-lamellar lipid compositions Jan 20, 2005 Issued
Array ( [id] => 5874030 [patent_doc_number] => 20060166220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Chimeric tumor suppressor gene and protein' [patent_app_type] => utility [patent_app_number] => 11/040219 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9302 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166220.pdf [firstpage_image] =>[orig_patent_app_number] => 11040219 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/040219
Chimeric tumor suppressor gene and protein Jan 20, 2005 Issued
Array ( [id] => 8188400 [patent_doc_number] => 08182834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Ternary non-lamellar lipid compositions' [patent_app_type] => utility [patent_app_number] => 10/586777 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 8860 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/182/08182834.pdf [firstpage_image] =>[orig_patent_app_number] => 10586777 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586777
Ternary non-lamellar lipid compositions Jan 20, 2005 Issued
Array ( [id] => 13322 [patent_doc_number] => 07807426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Processes for producing optically active 1-substituted 2-methylpyrrolidine' [patent_app_type] => utility [patent_app_number] => 10/586337 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5827 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807426.pdf [firstpage_image] =>[orig_patent_app_number] => 10586337 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586337
Processes for producing optically active 1-substituted 2-methylpyrrolidine Jan 18, 2005 Issued
Array ( [id] => 5614391 [patent_doc_number] => 20060116319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Method for identifying and treating photodamaged skin' [patent_app_type] => utility [patent_app_number] => 10/998685 [patent_app_country] => US [patent_app_date] => 2004-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6129 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116319.pdf [firstpage_image] =>[orig_patent_app_number] => 10998685 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/998685
Method for identifying and treating photodamaged skin Nov 28, 2004 Abandoned
Array ( [id] => 7097845 [patent_doc_number] => 20050130304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Regulation of endogenous gene expression in cells using zinc finger proteins' [patent_app_type] => utility [patent_app_number] => 10/986583 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 29754 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130304.pdf [firstpage_image] =>[orig_patent_app_number] => 10986583 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/986583
Regulation of endogenous gene expression in cells using zinc finger proteins Nov 11, 2004 Abandoned
Array ( [id] => 5045607 [patent_doc_number] => 20070264280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Compositions and Methods for Treating Neurological Diseases' [patent_app_type] => utility [patent_app_number] => 10/578561 [patent_app_country] => US [patent_app_date] => 2004-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16656 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264280.pdf [firstpage_image] =>[orig_patent_app_number] => 10578561 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/578561
Compositions and Methods for Treating Neurological Diseases Nov 7, 2004 Abandoned
Array ( [id] => 8114409 [patent_doc_number] => 08158420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Methods for inhibiting the differentation of proliferative telencephalic cells in vitro by addition of ATF5' [patent_app_type] => utility [patent_app_number] => 10/971483 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 34625 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158420.pdf [firstpage_image] =>[orig_patent_app_number] => 10971483 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/971483
Methods for inhibiting the differentation of proliferative telencephalic cells in vitro by addition of ATF5 Oct 21, 2004 Issued
Array ( [id] => 7811169 [patent_doc_number] => 08133699 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Minimal DNA sequence acting as a chromatin insulator and its use in protein expression' [patent_app_type] => utility [patent_app_number] => 10/576509 [patent_app_country] => US [patent_app_date] => 2004-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 6511 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133699.pdf [firstpage_image] =>[orig_patent_app_number] => 10576509 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/576509
Minimal DNA sequence acting as a chromatin insulator and its use in protein expression Oct 19, 2004 Issued
Array ( [id] => 92236 [patent_doc_number] => 07732420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Combinations of transfection lipids exhibiting increased transfection efficiencies' [patent_app_type] => utility [patent_app_number] => 10/957977 [patent_app_country] => US [patent_app_date] => 2004-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10058 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732420.pdf [firstpage_image] =>[orig_patent_app_number] => 10957977 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/957977
Combinations of transfection lipids exhibiting increased transfection efficiencies Oct 3, 2004 Issued
Array ( [id] => 92236 [patent_doc_number] => 07732420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Combinations of transfection lipids exhibiting increased transfection efficiencies' [patent_app_type] => utility [patent_app_number] => 10/957977 [patent_app_country] => US [patent_app_date] => 2004-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10058 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732420.pdf [firstpage_image] =>[orig_patent_app_number] => 10957977 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/957977
Combinations of transfection lipids exhibiting increased transfection efficiencies Oct 3, 2004 Issued
Array ( [id] => 5153838 [patent_doc_number] => 20070036721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Methods and compositions for in vivo inflammation monitoring' [patent_app_type] => utility [patent_app_number] => 10/572732 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 49777 [patent_no_of_claims] => 151 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036721.pdf [firstpage_image] =>[orig_patent_app_number] => 10572732 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/572732
Methods and compositions for in vivo inflammation monitoring Sep 22, 2004 Abandoned
10/935709 Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby Sep 6, 2004 Abandoned
Array ( [id] => 7154163 [patent_doc_number] => 20050026201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Method of modulating or examining Ku70 levels in cells' [patent_app_type] => utility [patent_app_number] => 10/924060 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15858 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026201.pdf [firstpage_image] =>[orig_patent_app_number] => 10924060 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/924060
Method of modulating or examining Ku70 levels in cells Aug 22, 2004 Abandoned
Array ( [id] => 7329858 [patent_doc_number] => 20040254134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Biological pacemaker' [patent_app_type] => new [patent_app_number] => 10/476259 [patent_app_country] => US [patent_app_date] => 2004-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 14647 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254134.pdf [firstpage_image] =>[orig_patent_app_number] => 10476259 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/476259
Biological pacemaker Aug 9, 2004 Abandoned
Menu